US Stock MarketDetailed Quotes

Mirum Pharmaceuticals (MIRM)

Watchlist
  • 91.850
  • -0.470-0.51%
Trading Jan 16 15:00 ET
4.75BMarket Cap-109.35P/E (TTM)

Mirum Pharmaceuticals (MIRM) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
Product sales, net133.01M100.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States274.17M81.38%
Rest of the world62.24M18.47%
License and other revenue479K0.14%
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More